Over one billion people smoke cigarettes globally. This habit is the leading cause for millions of preventable deaths yearly. Vaping was then positioned as a tool to reduce or quit smoking, having brought new pros and cons toward public health efforts. What then, could be used to help people quit vaping?

CAPNOS aims to educate and increase research interest in the field of sensory dependencies, as our devices are flavored, pressurized air inhalers for use as behavioral aids. We understand that the root craving often extends beyond nicotine, as shown by our CAPNOS Vaping Study Survey, published July 2024. 



Many people depend on vaping or smoking as a coping mechanism for stress or anxiety, to which an addiction often develops. We aim to further assess the efficacy of which CAPNOS devices can suppport habit reduction, replacement, or elimination efforts with vapes, through grant-funded research opportunities. Regulatory advocacy efforts are ongoing as we define a new product category that is neither a tobacco, nicotine, medical, or food item.



Academic research through laboratory studies are ongoing; we embrace challenging the status quo.